Propofol withdrawal syndrome in an adult patient with thermal injury

Pharmacotherapy

Volumn 23, Issue 7, 2003, Pages 933-939

  Cawley, Michael J ^a   Guse, Timothy M ^b   Laroia, Anjali ^c   Haith, Linwood R ^d   Ackerman, Bruce H ^d  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c CVS Caremark   (United States)

^d CROZER CHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLUOXETINE; HALOPERIDOL; LORAZEPAM; MORPHINE SULFATE; NEUROLEPTIC AGENT; OPIATE DERIVATIVE; PROPOFOL; RISPERIDONE; VALPROIC ACID;

ADULT; AGITATION; ALCOHOL ABUSE; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BIPOLAR DISORDER; BURN; CASE REPORT; CAUSE OF DEATH; DRUG INFUSION; DRUG INTOXICATION; DRUG WITHDRAWAL; DYING; HUMAN; HYPERPYREXIA; LIVER TOXICITY; MALE; MALIGNANT HYPERTHERMIA; MULTIPLE ORGAN FAILURE; PANCREATITIS; SEPTIC SHOCK; SIDE EFFECT; SMOKING; SYMPTOMATOLOGY; TACHYCARDIA; TACHYPNEA; THERMAL INJURY; TREMOR; WEANING; WITHDRAWAL SYNDROME;

BIPOLAR DISORDER; BURNS; ETHANOL; FATAL OUTCOME; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PROPOFOL; PSYCHOMOTOR AGITATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0038720006     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.7.933.32728     Document Type: Article

References (25)

1. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA 2000;283:1451-9.
2. Snellen F, Lauwers P, Demeyere R, Byttebier G, Van Aken H. The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting. Intensive Care Med 1990;16:312-16.
3. Farling PA, Johnston JR, Coppel DL. Propofol infusion for sedation of patients with head injury in intensive care: a preliminary report. Anaesthesia 1989;44:222-6.
4. McBurney JW, Teiken PJ, Moon MR. Propofol for treating status epilepticus. J Epilepsy 1994;7(1):21-2.
5. Mirenda J, Broyles G. Propofol as used for sedation in the ICU. Chest 1995;108:539-48.
6. Macdonald R. Benzodiazepines: mechanism of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs, 4th ed. New York: Raven Press, 1995:695-703.
7. Imray J, Hay A. Withdrawal syndrome after propofol [letter]. Anaesthesia 1991;46:704.
8. Au J, Walker WS, Scott DHT. Withdrawal syndrome after propofol infusion. Anaesthesia 1990;45:741-2.
9. Valente JF, Anderson GL, Branson RD, Johnson DJ, Davis K Jr, Poremka DT. Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med 1994;22:710-12.
10. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-41.
11. Soliman HM, Melot C, Vincent JL. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth 2001;87:186-92.
12. Weinbroum AA, Halpern P, Rudick V, Sorkine P, Freedman M, Geller E. Midazolam versus propofol for long-term sedation in the ICU. Intensive Care Med 1997;23:1258-63.
13. Metkus AP, Trabulsy PP, Schlobohm RS, Hickey MS. A firefighter with pancreatitis. Lancet 1996;348:1702.
14. Miller LJ, Wiles-Pfeifler R. Propofol for the long-term sedation of a critically ill patient. Amer J Crit Care 1998;7:73-6.
15. Boyle WA, Shear JM, White PF, Schuller D. Long-term sedative infusion in the intensive care unit: propofol vs midazolam. J Drug Dev 1991;4(suppl 3):43-5.
16. Carrasco G, Molina R, Costa J, Soler JM, Cabre L. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. Chest 1993;103:557-64.
17. Little HJ. The benzodiazepines: anxiolytic and withdrawal effects. Neuropeptides 1991;19(suppl):11-14.
18. Olmedo R, Hoffman RS. Withdrawal syndromes. Emerg Med Clin North Am 2000;18:273-88.
19. AstraZeneca Pharmaceuticals. Data on file. Wilmington, DE; 2002.
20. Cammarano WB, Pittet JF, Weitz S, Schlobohm RM, Marks JD. Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med 1998;26:676-84.
21. Fox FL, Bostwick JM. Propofol sedation of refractory delirious mania. Psychosomatics 1997;38:288-90.
22. Liao JS, Reiss WG. Drug-cytokine interactions: focus on cyclosporine. Pharmacotherapy 1996;16(3):401-8.
23. McKindley DS, Hanes S, Boucher BA. Hepatic drug metabolism in critical illness. Pharmacotherapy 1998;18(4):759-78.
24. Fulton B, Sorkin EM. Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995;50(4):636-57.
25. Taylor EH, Ackerman BH. Free drug monitoring by liquid chromatography and implications for therapeutic drug monitoring. J Liquid Chromatogr 1987;10(2-3):323-43.